PSR1,EFC15951,scenario1,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR2,EFC15951,scenario2,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR3,EFC15951,scenario3,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR4,EFC15951,scenario4,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR5,EFC15951,scenario5,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR6,EFC15951,scenario6,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR7,EFC15951,scenario7,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR8,EFC15951,scenario8,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR9,EFC15951,scenario9,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR10,EFC15951,scenario10,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR11,EFC15951,scenario11,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR12,EFC15951,scenario12,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR13,EFC15951,scenario13,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR14,EFC15951,scenario14,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR15,EFC15951,scenario15,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR16,EFC15951,scenario16,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR17,EFC15951,scenario17,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR18,EFC15951,scenario18,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR19,EFC15951,scenario19,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
PSR20,EFC15951,scenario20,3-4-2017,3-17-2023,NEW SCENARIO FOR THE PERF. TESTING,20,3000,1000,ap32877,Oncology,NCT01369108,ctfo_trial_11084
